DBAY strikes deal to buy Alliance Pharma for £350 million
Perhaps the chaps at Canaccord Genuity's Quest were onto something after all with theory about how London-listed small and mid cap stocks will continue to disappear from the stock market.
You need to register and sign in to read this content.
